Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/34314
Title: Behcet Disease Clinical Features and Management in a Brazilian Tertiary Hospital
Authors: Diniz Oliveira, Ana Cecilia [UNIFESP]
Pirozzi Buosi, Ana Leticia [UNIFESP]
Dutra, Livia Almeida [UNIFESP]
Silva de Souza, Alexandre Wagner [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Keywords: Behcet syndrome
uveitis
colchicine
immunosuppressive agents
Issue Date: 1-Dec-2011
Publisher: Lippincott Williams & Wilkins
Citation: Jcr-Journal of Clinical Rheumatology. Philadelphia: Lippincott Williams & Wilkins, v. 17, n. 8, p. 416-420, 2011.
Abstract: Background: Behcet disease (BD) is prevalent in Central and East Asia and in the Eastern Mediterranean area where most studies have been performed. Few studies have evaluated patients with BD in Brazil.Objectives: the objective of the study was to describe clinical manifestations of BD and their therapy in a single center in Brazil.Methods: Sixty patients who met the International Study Group Criteria for BD and were under follow-up at the Vasculitis Unit of the Universidade Federal de São Paulo were evaluated in a retrospective observational study.Results: Mean age at study was 40.0 (SD, 10.7) years, and the femalemale ratio was 1.2:1.0. the frequency of disease manifestations was as follows: oral ulcers, 100%; genital ulcers, 93.3%; ocular manifestations, 63.3%; arthritis, 46.7%; cutaneous lesions, 71.7%; positive pathergy test, 22.7%; neurologic involvement, 28.3%; thrombosis, 13.3%; and gastrointestinal involvement, 3.3%. Arthritis and erythema nodosum were more prevalent among women, whereas papulopustular lesions were more common in men. the frequency of each treatment modality was as follows: colchicine, 78.3%; thalidomide, 26.7%; colchicine and penicillin, 21.7%; dapsone, 8.3%; and pentoxyphyline, 8.3%. These treatments were mainly used for mucocutaneous manifestations. Immunosuppressive drugs were prescribed for 70% of the patients, including azathioprine (35.0%), cyclophosphamide (28.3%), cyclosporin A (21.7%), methotrexate (18.3%), and chlorambucil (6.7%). Infliximab was used in 5.0% of refractory patients. No differences were observed between sexes related to severe manifestations of BD.Conclusions: Although reported elsewhere, Brazilian men with BD did not have a worse prognosis. Women had a higher frequency of arthritis manifestations.
URI: http://repositorio.unifesp.br/handle/11600/34314
ISSN: 1076-1608
Other Identifiers: http://dx.doi.org/10.1097/RHU.0b013e31823a46ed
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.